Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Creager

Showing results (31-40 of 349) with videos related to

Pageof 35
Sort By:
Circulation|September 4, 2003
Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial diseaseEmile R Mohler, William R Hiatt, Mark A Creager
Circulation|May 1, 1987
Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistanceA T Hirsch, V J Dzau, M A Creager
NEJM Catalyst Innovations in Care Delivery|July 15, 2026
Toward Sustainable and Equitable Rural Health - Recommendations for Multisector ActionAmber E Barnato, Sally A Kraft, Mark A Creager
Circulation Research|June 10, 2021
Contemporary Medical Management of Peripheral Artery DiseaseMarc P Bonaca, Naomi M Hamburg, Mark A Creager
The American Journal of Physiology|September 1, 1996
Endothelium-derived nitric oxide mediates hypoxic vasodilation of resistance vessels in humansM L Blitzer, S D Lee, M A Creager
Vascular Medicine (London, England)|March 29, 2008
A randomized trial of iloprost in patients with intermittent claudicationMark A Creager, Reena L Pande, William R Hiatt
Circulation|August 23, 2006
The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit?Joshua A Beckman, Michael R Jaff, Mark A Creager
The American Journal of Cardiology|January 15, 1989
Relation of atrial natriuretic factor to vasoconstrictor hormones and regional blood flow in congestive heart failureA T Hirsch, M A Creager, V J Dzau
Journal of the American College of Cardiology|March 18, 1999
Effect of intensive therapy for heart failure on the vasodilator response to exerciseW Johnson, C Lucas, L W Stevenson, et al.
European Heart Journal|May 4, 2013
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part IFrancesco Paneni, Joshua A Beckman, Mark A Creager, et al.
Pageof 35

Showing results (31-40 of 349) with videos related to

Sort By:
Pageof 35
Circulation|September 4, 2003
Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial diseaseEmile R Mohler, William R Hiatt, Mark A Creager
Circulation|May 1, 1987
Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistanceA T Hirsch, V J Dzau, M A Creager
NEJM Catalyst Innovations in Care Delivery|July 15, 2026
Toward Sustainable and Equitable Rural Health - Recommendations for Multisector ActionAmber E Barnato, Sally A Kraft, Mark A Creager
Circulation Research|June 10, 2021
Contemporary Medical Management of Peripheral Artery DiseaseMarc P Bonaca, Naomi M Hamburg, Mark A Creager
The American Journal of Physiology|September 1, 1996
Endothelium-derived nitric oxide mediates hypoxic vasodilation of resistance vessels in humansM L Blitzer, S D Lee, M A Creager
Vascular Medicine (London, England)|March 29, 2008
A randomized trial of iloprost in patients with intermittent claudicationMark A Creager, Reena L Pande, William R Hiatt
Circulation|August 23, 2006
The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit?Joshua A Beckman, Michael R Jaff, Mark A Creager
The American Journal of Cardiology|January 15, 1989
Relation of atrial natriuretic factor to vasoconstrictor hormones and regional blood flow in congestive heart failureA T Hirsch, M A Creager, V J Dzau
Journal of the American College of Cardiology|March 18, 1999
Effect of intensive therapy for heart failure on the vasodilator response to exerciseW Johnson, C Lucas, L W Stevenson, et al.
European Heart Journal|May 4, 2013
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part IFrancesco Paneni, Joshua A Beckman, Mark A Creager, et al.
Pageof 35